The New York Times became the latest major news outlet to dig deeper into the increasing number of woman across the U.S. with ovarian cancer to sue health-care giant Johnson & Johnson.
The story explores the numerous studies that point to talcum in J&J’s Baby Powder and Shower to Shower Powder increasing the risk of women developing ovarian cancer.
The article follows two huge jury verdicts – one for $72 million, the other for $55 million – against J&J this year involving talcum-ovarian cancer lawsuits.
Ross Feller Casey is pursuing lawsuits against Johnson & Johnson on behalf of hundreds of women from across the country.
If you or a loved one has been diagnosed with ovarian cancer, used Johnson & Johnson Baby Powder or Shower to Shower on genital areas or on sanitary napkins or diaphragms for an extended time, you should contact one of our experienced talcum powder lawyers for a no-cost case review.
To learn more, go to Talcum Ovarian Cancer Lawsuits